Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

Related Articles by Review for PubMed (Select 20388114)

1.

PET with non-standard nuclides.

Hao G, Singh AN, Liu W, Sun X.

Curr Top Med Chem. 2010;10(11):1096-112. Review.

PMID:
20388114
2.

Unconventional nuclides for radiopharmaceuticals.

Holland JP, Williamson MJ, Lewis JS.

Mol Imaging. 2010 Feb;9(1):1-20. Review.

PMID:
20128994
3.

Image quality with non-standard nuclides in PET.

Laforest R, Liu X.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):151-8. Epub 2007 Nov 28. Review.

4.

Recent advances in copper radiopharmaceuticals.

Hao G, Singh AN, Oz OK, Sun X.

Curr Radiopharm. 2011 Apr;4(2):109-21. Review.

PMID:
22191650
5.

Decay data and production yields of some non-standard positron emitters used in PET.

Qaim SM.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):111-20. Epub 2008 Jan 5. Review.

6.

Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides.

Welch MJ, Laforest R, Lewis JS.

Ernst Schering Res Found Workshop. 2007;(62):159-81. Review.

PMID:
17172155
7.

Neuronuclear assessment of patients with epilepsy.

Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W.

Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004. Review.

PMID:
18514079
8.

The search for consistency in the manufacture of PET radiopharmaceuticals.

Finn RD.

Ann Nucl Med. 1999 Dec;13(6):379-82. Review.

PMID:
10656270
9.

Non-standard radionuclide production for PET in Japan.

Fujibayashi Y, Suzuki K, Fukumura T, Mori T, Kasamatsu S.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):140-4. Epub 2007 Nov 28. Review.

10.
11.

Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.

Chua S, Gnanasegaran G, Cook GJ.

Semin Nucl Med. 2009 Nov;39(6):416-30. doi: 10.1053/j.semnuclmed.2009.07.002. Review.

PMID:
19801221
12.

PET & SPECT instrumentation.

Spanoudaki VC, Ziegler SI.

Handb Exp Pharmacol. 2008;(185 Pt 1):53-74. doi: 10.1007/978-3-540-72718-7_3. Review.

PMID:
18626798
13.

Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.

Ghesani M, Depuey EG, Rozanski A.

Echocardiography. 2005 Feb;22(2):165-77. Review.

PMID:
15693785
14.

Cardiac positron emission tomography imaging.

Machac J.

Semin Nucl Med. 2005 Jan;35(1):17-36. Review.

PMID:
15645392
15.

Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.

Hohn A, Zimmermann K, Schaub E, Hirzel W, Schubiger PA, Schibli R.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):145-50. Epub 2008 Jan 5. Review.

17.

99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers.

Liu S, Chakraborty S.

Dalton Trans. 2011 Jun 21;40(23):6077-86. doi: 10.1039/c0dt01462a. Epub 2011 Mar 3. Review.

PMID:
21373664
18.

Targeting peptides and positron emission tomography.

Lundqvist H, Tolmachev V.

Biopolymers. 2002;66(6):381-92. Review.

PMID:
12658725
19.

Single photon emission computed tomography and positron emission tomography in cancer imaging.

Coleman RE.

Cancer. 1991 Feb 15;67(4 Suppl):1261-70. Review.

PMID:
1991287
20.

Radionuclide production and yields at Washington University School of Medicine.

Tang L.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):121-33. Epub 2007 Nov 28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk